company background image
PBH logo

Prestige Consumer Healthcare NYSE:PBH Voorraadrapport

Laatste prijs

US$74.77

Marktkapitalisatie

US$3.7b

7D

1.7%

1Y

24.9%

Bijgewerkt

05 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Prestige Consumer Healthcare Inc.

NYSE:PBH Voorraadrapport

Marktkapitalisatie: US$3.7b

PBH Overzicht aandelen

Prestige Consumer Healthcare Inc. ontwikkelt, vervaardigt, verkoopt, distribueert en verkoopt vrij verkrijgbare (OTC) gezondheids- en persoonlijke verzorgingsproducten in Noord-Amerika, Australië en internationaal.

Over het bedrijf

Beloningen

Verhandeld tegen 52.1% onder onze schatting van de reële waarde
De winst zal naar verwachting met 4.98% per jaar groeien
Dit jaar winstgevend geworden
Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Heeft een hoog schuldenniveau

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Brand Building And Innovations Propel Long-Term Growth Amid Supply Chain Challenges

Key Takeaways Investments in brand building and marketing for key products like Hydralyte and Summer's Eve are enhancing consumer awareness and driving revenue growth. Effective supply chain management and strategic product innovations are positioning Prestige Consumer Healthcare for increased market share and international expansion.
View narrative
US$79.43
FV
5.9% undervalued intrinsic discount
2.43%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 days ago author updated this narrative

Prestige Consumer Healthcare Inc. Concurrenten

Organon

NYSE:OGN

US$4.4b

Corcept Therapeutics

NasdaqCM:CORT

US$5.2b

Amphastar Pharmaceuticals

NasdaqGS:AMPH

US$2.5b

Jazz Pharmaceuticals

NasdaqGS:JAZZ

US$6.8b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Prestige Consumer Healthcare
Historische aandelenkoersen
Huidige aandelenkoersUS$74.77
52 Week HoogtepuntUS$75.80
52 Week LaagUS$56.61
Bèta0.47
11 maand verandering8.63%
3 maanden verandering10.13%
1 Jaar Verandering24.87%
33 jaar verandering19.48%
5 jaar verandering98.07%
Verandering sinds IPO321.24%

Recent nieuws en updates

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Recent updates

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jun 14
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Rendement voor aandeelhouders

PBHUS PharmaceuticalsUS Markt
7D1.7%-4.8%-0.8%
1Y24.9%14.1%31.5%

Rendement versus industrie: PBH overtrof de US Pharmaceuticals industrie, die het afgelopen jaar een rendement 14.1 % opleverde.

Rendement versus markt: PBH presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 31.5 % opleverde.

Prijsvolatiliteit

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.0%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.8%

Stabiele aandelenkoers: PBH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van PBH is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1996570Ron Lombardiwww.prestigebrands.com

Prestige Consumer Healthcare Inc. ontwikkelt, produceert, verkoopt en distribueert samen met zijn dochterondernemingen vrij verkrijgbare (OTC) gezondheids- en persoonlijke verzorgingsproducten in Noord-Amerika, Australië en internationaal. Het bedrijf opereert in twee segmenten, Noord-Amerikaanse OTC Healthcare en Internationale OTC Healthcare. Het bedrijf biedt pijnstillende poeders onder de merknamen BC en Goody's; behandelingen tegen luieruitslag en huidbescherming voor baby's onder de merknaam Boudreaux's Butt Paste; sprays en zuigtabletten tegen keelpijn en mondpijn onder de merknaam Chloraseptic; oogverzorgingsproducten die verlichting bieden bij roodheid en jeuk onder de merknaam Clear Eyes; thuisbehandeling voor het verwijderen van gewone wratten en plantaire wratten onder de merknaam Compound W; en Debrox voor het verwijderen van oorsmeer.

Prestige Consumer Healthcare Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Prestige Consumer Healthcare zich tot de beurswaarde?
PBH fundamentele statistieken
MarktkapitalisatieUS$3.66b
Inkomsten(TTM)US$205.13m
Inkomsten(TTM)US$1.11b

18.1x

Koers/Winstverhouding

3.3x

P/S-verhouding

Is PBH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
PBH resultatenrekening (TTM)
InkomstenUS$1.11b
Kosten van inkomstenUS$488.83m
BrutowinstUS$624.36m
Overige uitgavenUS$419.23m
InkomstenUS$205.13m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 07, 2024

Winst per aandeel (EPS)4.14
Brutomarge56.09%
Nettowinstmarge18.43%
Schuld/Eigen Vermogen Verhouding64.9%

Hoe presteerde PBH op de lange termijn?

Bekijk historische prestaties en vergelijking